Jazz Pharmaceuticals Plc Earnings

Jazz Pharmaceuticals Plc’s revenue jumped 2.14% since last year same period to $1045.71Mn in the Q2 2025. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 16.47% jump in its revenue since last 3-months.

Jazz Pharmaceuticals Plc’s net profit fell -526.22% since last year same period to $-718.47Mn in the Q2 2025. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated -676.38% fall in its net profits since last 3-months.

Jazz Pharmaceuticals Plc’s net profit margin fell -517.3% since last year same period to -68.71% in the Q2 2025. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated -566.59% fall in its net profit margins since last 3-months.

Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current quarter stand at 5.96 - a 178.22% jump from last quarter’s estimates.

Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current year stand at 5.96.

Jazz Pharmaceuticals Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Jazz Pharmaceuticals Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.